Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Regional control and morbidity after superficial groin dissection in melanoma.

Shada AL, Slingluff CL Jr.

Ann Surg Oncol. 2011 May;18(5):1453-9. doi: 10.1245/s10434-010-1450-0. Epub 2010 Dec 7.

2.

Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.

van der Ploeg AP, van Akkooi AC, Schmitz PI, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C.

Ann Surg Oncol. 2011 Nov;18(12):3300-8. doi: 10.1245/s10434-011-1741-0. Epub 2011 May 3.

3.

Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.

Niebling MG, Wevers KP, Suurmeijer AJ, van Ginkel RJ, Hoekstra HJ.

Ann Surg Oncol. 2015 Jan;22(1):279-86. doi: 10.1245/s10434-014-3854-8. Epub 2014 Jul 10.

PMID:
25008028
4.

Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?

van der Ploeg IM, Valdés Olmos RA, Kroon BB, Nieweg OE.

Ann Surg Oncol. 2008 May;15(5):1485-91. doi: 10.1245/s10434-008-9840-2. Epub 2008 Mar 7.

PMID:
18324444
5.

Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.

Oude Ophuis CM, van Akkooi AC, Hoekstra HJ, Bonenkamp JJ, van Wissen J, Niebling MG, de Wilt JH, van der Hiel B, van de Wiel B, Koljenović S, Grünhagen DJ, Verhoef C.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1172-80. doi: 10.1245/s10434-015-4602-4. Epub 2015 May 27.

6.

Is superficial inguinal node dissection adequate for regional control of malignant melanoma in patients with N1 disease?

Smith OJ, Rimouche S, Oudit D, Mowatt D, Ross GL.

J Plast Reconstr Aesthet Surg. 2013 Apr;66(4):472-7. doi: 10.1016/j.bjps.2012.12.020. Epub 2013 Feb 4.

PMID:
23391539
7.

Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?

Wevers KP, Bastiaannet E, Poos HP, van Ginkel RJ, Plukker JT, Hoekstra HJ.

Ann Surg Oncol. 2012 Nov;19(12):3913-8. doi: 10.1245/s10434-012-2401-8. Epub 2012 May 17.

8.

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.

Mozzillo N, Caracò C, Marone U, Di Monta G, Crispo A, Botti G, Montella M, Ascierto PA.

World J Surg Oncol. 2013 Feb 4;11:36. doi: 10.1186/1477-7819-11-36.

9.

Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.

Egger ME, Brown RE, Roach BA, Quillo AR, Martin RC 2nd, Scoggins CR, Stromberg AJ, McMasters KM.

J Am Coll Surg. 2014 Jul;219(1):101-8. doi: 10.1016/j.jamcollsurg.2014.02.019. Epub 2014 Mar 2.

PMID:
24726566
11.

Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.

Allan CP, Hayes AJ, Thomas JM.

ANZ J Surg. 2008 Nov;78(11):982-6. doi: 10.1111/j.1445-2197.2008.04716.x.

PMID:
18959697
12.

Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population.

Spillane AJ, Haydu L, McMillan W, Stretch JR, Thompson JF.

Ann Surg Oncol. 2011 Sep;18(9):2521-8. doi: 10.1245/s10434-011-1755-7. Epub 2011 May 10.

PMID:
21556951
13.

Positive iliac and obturator nodes in melanoma: survival and prognostic factors.

Strobbe LJ, Jonk A, Hart AA, Nieweg OE, Kroon BB.

Ann Surg Oncol. 1999 Apr-May;6(3):255-62.

PMID:
10340884
14.

Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL.

Arch Surg. 2006 Sep;141(9):877-82; discussion 882-4.

PMID:
16983031
15.

Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.

Glover AR, Allan CP, Wilkinson MJ, Strauss DC, Thomas JM, Hayes AJ.

Br J Surg. 2014 Jun;101(7):811-9. doi: 10.1002/bjs.9502. Epub 2014 Apr 22.

PMID:
24752717
16.

Cloquet's node trumps imaging modalities in the prediction of pelvic nodal involvement in patients with lower limb melanomas in Asian patients with palpable groin nodes.

Koh YX, Chok AY, Zheng H, Xu S, Teo MC.

Eur J Surg Oncol. 2014 Oct;40(10):1263-70. doi: 10.1016/j.ejso.2014.05.008. Epub 2014 Jun 5.

PMID:
24947073
17.

Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, Wong SL, Cimmino VM, Chang AE.

Surgery. 2007 Jun;141(6):728-35.

PMID:
17560249
18.

Is the node of Cloquet the sentinel node for the iliac/obturator node group?

Shen P, Conforti AM, Essner R, Cochran AJ, Turner RR, Morton DL.

Cancer J. 2000 Mar-Apr;6(2):93-7.

PMID:
11069226
19.

[Inguinal recurrence after therapeutic lymphadenectomy in malignant melanoma].

Kretschmer L, Lautenschläger C, Preusser KP, Fiedler H.

Langenbecks Arch Chir. 1993;378(4):211-6. German.

PMID:
8366734
20.

The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.

Zdzienicki M, Rutkowski P, Nowecki ZI, van Akkooi AC, Michej W, Dziewirski W, Świtaj T, Pieńkowski A, Sałamacha M, Bylina E, Eggermont AM.

Eur J Surg Oncol. 2013 Mar;39(3):304-10. doi: 10.1016/j.ejso.2012.12.014. Epub 2013 Jan 5.

PMID:
23298828

Supplemental Content

Support Center